Navigation Links
Laureate Pharma Elects New Board Member
Date:8/18/2009

PRINCETON, N.J., Aug. 18 /PRNewswire/ -- Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company, today announced the Election of Joel A. Tune as a new member of its Board of Directors.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080131/NETH020LOGO )

Along with providing expert guidance and strategic direction focused on Laureate's contract manufacturing business, Mr. Tune brings to Laureate more than 20 years of experience in P&L, strategy, operations, marketing and engineering leadership, in rapid-growth and transitional health products and service businesses. Throughout his career, he has worked in general management, sales and marketing, strategy, business development and engineering.

"Joel's exceptional mix of contract manufacturing expertise, in-depth knowledge of customer needs, and strong leadership skills will enable us to propel Laureate's growth and development and to achieve worldwide recognition for our fully-integrated contract development and bioprocessing services," said Robert J. Broeze, Ph.D., President & Chief Executive Officer of Laureate." As we continue to enhance the value proposition for our customers and to continue to build upon our momentum, we look to our new partnership with Joel to help aid in achieving our objectives for 2009 and beyond."

Mr. Tune most recently served as Vice President / General Manager, Global Drug Delivery of Baxter International where he transformed an established business, doubling revenues over five years to reach $800M+. Mr. Tune realigned the business model, products and market focus toward high value, rapidly expanding outsourcing services and technologies. He also successfully led a 14-member leadership team; 200 business development, sales and marketing, and product development professionals; over 800 employees in a dedicated facility; and effectively directed shared services production operations with 13 global manufacturing facilities. He concurrently, served on Baxter's senior management team with active involvement in cross-business communications, investor relations and industry outreach awareness. Previously, he was Vice President, Strategy & Business Development for Baxter and was responsible for in-house strategy and venture development. He orchestrated cross-divisional initiatives to create value within Baxter's largest product and distribution operations.

About Laureate Pharma

Laureate Pharma is a full-service biopharmaceutical development and protein production company located in Princeton, New Jersey. Laureate Pharma offers superior bioprocessing services that accelerate new products from development through production. Laureate provides a wide range of specialized services from process design and development to full-scale cGMP production, purification, aseptic filling, testing, validation, analytical services, and regulatory support. Laureate is focused on two active segments of the biopharmaceutical industry: monoclonal antibodies and recombinant protein products. For more information, contact Robert J. Broeze, Ph.D., President & CEO at (609) 919-3400, or info@laureatepharma.com or visit www.laureatepharma.com.

Available Topic Experts: For information on the listed experts, click appropriate link.

Robert Broeze

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=84360


'/>"/>
SOURCE Laureate Pharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Laureate Pharma Appoints Daniel E. Leone as Vice President of Business Development
2. Nobel Laureate Lee Hartwell to Retire as President and Director of Fred Hutchinson Cancer Research Center in 2010
3. US Oncology Named 2009 Laureate by IDG Computerworld Honors Program
4. Nobel Laureates to Speak at Keystone Symposia RNA Silencing Conference
5. Laureate Pharma Honored as Emerging Life Sciences Company of the Year
6. Laureate Pharma Announces Agreement with Tolera Therapeutics, Inc.
7. Laureate Announces Manufacturing Agreement with Tolerx
8. Laureate Pharma to Add More Manufacturing Capacity
9. ARUP Laboratories ARUP Consult(R) Recognized as a Computerworld Honors Program Laureate
10. Laureate Pharma Announces Manufacturing Agreement With Alopexx Pharmaceuticals, LLC
11. Laureate Pharma Reports Record Growth for 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)...  ArmaGen, Inc., today announced that it has ... executive officer, as well as a member of ... more than 17 years of executive management experience ... and pharmaceuticals. "Mathias is a ... skillset necessary to lead ArmaGen to its next ...
(Date:1/19/2017)... ... January 18, 2017 , ... The American Medical ... update its Data Sharing Policy. Specifically, the nation’s leading informatics experts, said data ... the existing policy. AMIA recommended that NIH earmark funding for researchers to produce ...
(Date:1/19/2017)... ... January 19, 2017 , ... FireflySci Inc. is a go-getter type ... tremendous growth is accounted to two main factors. The first is the amazing ... of vendors supplying FireflySci products all around the world. , 2016 was a tremendous ...
(Date:1/19/2017)... YORK , Jan. 18, 2017 ... to reach USD 92.9 billion by 2025, according ... Inc. Pharmaceutical industry has been adaptive of the ... as early as 2002. Among the services outsourced, ... forerunners. For instance, Johnson & Johnson was the ...
Breaking Biology Technology:
(Date:1/18/2017)... Minn. , Jan. 18, 2017 ... technology company that supports the entire spectrum of ... has been another record-breaking year for the organization ... market interest in MedNet,s eClinical products and services. ... the tremendous marketplace success of iMedNet ...
(Date:1/12/2017)... -- Trovagene, Inc. (NASDAQ: TROV ), a developer ... it has signed agreements with seven strategic partners across ... Middle East for commercialization of the Trovera™ ... of international distribution agreements for Trovagene,s CLIA based liquid ... The initial partners will introduce Trovagene,s liquid biopsy tests ...
(Date:1/12/2017)... , January 12, 2017 A new report by Allied Market ... the global biometric technology market is expected to generate revenue of $10.72 billion by ... Continue Reading ... Allied Market Research Logo ...      (Logo: http://photos.prnewswire.com/prnh/20140911/647229) ...
Breaking Biology News(10 mins):